This website is intended for healthcare professionals only

Trending Topic

16 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Hypertension is the leading modifiable risk factor for global cardiovascular disease, responsible for an estimated 10.8 million deaths and more than 200 million disability-adjusted life years annually.1 Despite the availability of effective pharmacological and lifestyle interventions, prevalence continues to rise, particularly in low- and middle-income countries (LMICs), where over three-quarters of all cases now occur.2 The condition’s […]

177/Efficacy of biventricular stimulation after radiofrequency ablation of AV node in patients with persistent atrial fibrillation

BA Akhyt (Presenting Author) – Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan; RR Rekvava – Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan; KM Koshumbayeva – Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan; KN Madaliev – Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan; RT Kuanyshbekova – Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan
< 1 min
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Oct 3rd 2008 European Journal of Arrhythmia & Electrophysiology. 2019;5(Suppl. 1):abstr177
Select a Section…
1

Article

Objective: To evaluate the effectiveness of biventricular stimulation after the destruction of AV-node in patients with persistent atrial fibrillation (AF) and chronic heart failure (CHF).

Materials and methods: The observational single-centre study included 34 patients with mean age 61,8 ± 9.4 years. All the patients were diagnosed with CHF functional classes III, IV according to New York Heart Association (NYHA) and had poorly controlled persistent AF. At the enrolment point, patients received beta-blockers, ACE inhibitors, diuretics (including aldosterone antagonists), antiplatelet agents, anticoagulants, and statins (if indicated). Radiofrequency ablation of the AV node with implantation of a resynchronisation device (biventricular stimulation) were performed in all patients. Before and 12 months after the intervention we utilized an echocardiography to evaluate cardiac structure and its functions.

Results: The follow-up showed that 12 months after the intervention, there was an increase in the left ventricular ejection fraction (EF) from 32.95 ± 6.84% to 42.89 ± 8.91% (p<0.0001). We observed a decrease in the end-systolic volume (ESV) from 113.32 ± 48.54 ml to 93.83 38.3 ml (p<0.0001). There were no changes on the left ventricular stroke volume (73.41 ± 15.56 ml at the baseline compared with 74.26 ± 20.56 ml 12 months later, p<0.737). The six-minute walk test (SMWT) results increased from 241.3 ± 56.2 m to 362.1 ± 72.2 (p<0.0001).

Conclusions: Biventricular stimulation after radiofrequency ablation of AV node in patients with poorly controlled persistent atrial fibrillation, advanced CHF resulted with an EF, and SMWT improvement, as well as ESV decrease within 12 months observation period.

2

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup